Treatment of Moderate-to-severe Atopic Dermatitis with Upadacitinib: Results from an Interim Analysis of the TREATgermany Registry

Antzeko izenburuak

• Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient
  nork: Mara Giavina-Bianchi, MD, PhD, et al.
  Argitaratua: (2024-08-01)
• Treatment of Moderate-to-severe Atopic Dermatitis with Upadacitinib: Results from an Interim Analysis of the TREATgermany Registry
  nork: Barbara Kind, et al.
  Argitaratua: (2025-05-01)
• Successful Achievement of Demanding Outcomes in Upadacitinib-Treated Atopic Dermatitis Patients: A Real-World, 96-Week Single-Centre Study
  nork: Stamatios Gregoriou, et al.
  Argitaratua: (2025-01-01)
• Amenorrhea in an Adolescent Female as a Rare Adverse Event of Upadacitinib Treatment for Atopic Dermatitis
  nork: Teng Y, et al.
  Argitaratua: (2024-11-01)
• Use of upadacitinib in the treatment of moderate to severe atopic dermatitis: patient profiling, dose selection, and therapy modulation, what does real-life teach us?
  nork: Edoardo Mortato, et al.
  Argitaratua: (2025-12-01)